157 related articles for article (PubMed ID: 36056953)
1. Measuring the indirect cost associated with advanced non-small cell lung cancer: a nationwide cross-sectional study in China.
Yang Y; Xia Y; Su C; Chen J; Long E; Zhang H; Gan Y; Yan F; Chen Y
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4205-4214. PubMed ID: 36056953
[TBL] [Abstract][Full Text] [Related]
2. Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stage.
Wood R; Taylor-Stokes G
BMC Cancer; 2019 Mar; 19(1):214. PubMed ID: 30849964
[TBL] [Abstract][Full Text] [Related]
3. Measuring direct non-medical burden among patients with advanced non-small cell lung cancer in China: is there a difference in health status?
Xia Y; Chen Y; Chen J; Gan Y; Su C; Zhang H; Long E; Yan F; Yang Y
Front Public Health; 2023; 11():1090623. PubMed ID: 37213608
[TBL] [Abstract][Full Text] [Related]
4. Economic burden of advanced lung cancer patients treated by gefitinib alone and combined with chemotherapy in two regions of China.
Yang K; Hua S; Wei W; Yang C; Zhu X; Li SC
J Med Econ; 2023; 26(1):1424-1431. PubMed ID: 37855437
[TBL] [Abstract][Full Text] [Related]
5. A Systematic Review of the Cost-Effectiveness Analyses of Anaplastic Lymphoma Kinase (ALK) Inhibitors in Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC).
Chayab L; Konstantelos N; Leighl NB; Tadrous M; Wong WWL
Pharmacoeconomics; 2023 Aug; 41(8):945-980. PubMed ID: 37268866
[TBL] [Abstract][Full Text] [Related]
6. Does caring for patients with advanced non-small cell lung cancer affect health-related quality of life of caregivers? A multicenter, cross-sectional study.
Yang Y; Liu L; Chen J; Gan Y; Su C; Zhang H; Long E; Yan F; Chen Y
BMC Public Health; 2024 Jan; 24(1):224. PubMed ID: 38238722
[TBL] [Abstract][Full Text] [Related]
7. A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506).
Zhou Q; Song Y; Zhang X; Chen GY; Zhong DS; Yu Z; Yu P; Zhang YP; Chen JH; Hu Y; Feng GS; Song X; Shi Q; Yang LL; Zhang PH; Wu YL
BMC Cancer; 2017 Jul; 17(1):462. PubMed ID: 28673332
[TBL] [Abstract][Full Text] [Related]
8. The humanistic burden associated with caring for patients with advanced non-small cell lung cancer (NSCLC) in three European countries-a real-world survey of caregivers.
Wood R; Taylor-Stokes G; Lees M
Support Care Cancer; 2019 May; 27(5):1709-1719. PubMed ID: 30121787
[TBL] [Abstract][Full Text] [Related]
9. The humanistic burden of advanced non-small cell lung cancer (NSCLC) in Europe: a real-world survey linking patient clinical factors to patient and caregiver burden.
Wood R; Taylor-Stokes G; Smith F; Chaib C
Qual Life Res; 2019 Jul; 28(7):1849-1861. PubMed ID: 30825160
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with gene aberration test status and treatment decision in patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer: A multicenter survey in China (CTONG 1506).
Song Y; Zhou Q; Zhang X; Chen GY; Zhong DS; Yu Z; Yu P; Zhang YP; Chen JH; Hu Y; Feng GS; Song X; Shi Q; Yang LL; Yao LD; Zhan LJ; Yang F; Wu YL
Lung Cancer; 2018 Sep; 123():7-13. PubMed ID: 30089597
[TBL] [Abstract][Full Text] [Related]
11. Economic Burden for Lung Cancer Survivors in Urban China.
Zhang X; Liu S; Liu Y; Du J; Fu W; Zhao X; Huang W; Zhao X; Liu G; Mao Z; Hu TW
Int J Environ Res Public Health; 2017 Mar; 14(3):. PubMed ID: 28294998
[TBL] [Abstract][Full Text] [Related]
12. Caregiver burden for informal caregivers of patients after surgical treatment of early-stage lung cancer.
Zhu S; Yang C; Mei W; Kang L; Li T; Li J; Li L
J Clin Nurs; 2023 Mar; 32(5-6):859-871. PubMed ID: 35869414
[TBL] [Abstract][Full Text] [Related]
13. Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS).
Andreas S; Chouaid C; Danson S; Siakpere O; Benjamin L; Ehness R; Dramard-Goasdoue MH; Barth J; Hoffmann H; Potter V; Barlesi F; Chirila C; Hollis K; Sweeney C; Price M; Wolowacz S; Kaye JA; Kontoudis I
Lung Cancer; 2018 Oct; 124():298-309. PubMed ID: 29961557
[TBL] [Abstract][Full Text] [Related]
14. Health care resource utilization and costs associated with advanced or metastatic nonsmall cell lung cancer in the United States.
Zhang X; Beachler DC; Masters E; Liu F; Yang M; Dinh J; Jamal-Allial A; Kolitsopoulos F; Lamy FX
J Manag Care Spec Pharm; 2022 Feb; 28(2):255-265. PubMed ID: 34854733
[No Abstract] [Full Text] [Related]
15. Economic evaluation of sintilimab plus chemotherapy vs. pembrolizumab plus chemotherapy for the treatment of first-line advanced or metastatic squamous NSCLC.
Chen P; Wang X; Zhu S; Li H; Rui M; Wang Y; Sun H; Ma A
Front Public Health; 2022; 10():956792. PubMed ID: 36016894
[TBL] [Abstract][Full Text] [Related]
16. The present and future burden of previously treated advanced non-small cell lung cancer (NSCLC) by histology and line of therapy in France, Germany, Italy, and Spain: model-based predictions.
Campbell D; O'Day K; Hertel N; Penrod JR; Manley Daumont M; Lees M
Popul Health Metr; 2018 Nov; 16(1):17. PubMed ID: 30477516
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain.
De Castro J; Insa A; Collado-Borrell R; Escudero-Vilaplana V; Martínez A; Fernandez E; Sullivan I; Arrabal N; Carcedo D; Manzaneque A
BMC Pulm Med; 2023 Feb; 23(1):69. PubMed ID: 36809990
[TBL] [Abstract][Full Text] [Related]
18. Informal caregiving burden in advanced non-small cell lung cancer: the HABIT study.
Gridelli C; Ferrara C; Guerriero C; Palazzo S; Grasso G; Pavese I; Satta F; Bajetta E; Cortinovis D; Barbieri F; Gebbia V; Grossi F; Novello S; Baldini E; Gasparini G; Latino W; Durante E; Giustini L; Negrini C
J Thorac Oncol; 2007 Jun; 2(6):475-80. PubMed ID: 17545841
[TBL] [Abstract][Full Text] [Related]
19. Association between the patients' symptom burden and their family caregivers' benefit finding in non-small cell lung cancer receiving combined chemotherapy.
Ma L; Zhu K; Shi C; Chen X; Gao Y; Cai C; Wang Y
Support Care Cancer; 2023 Feb; 31(2):148. PubMed ID: 36729306
[TBL] [Abstract][Full Text] [Related]
20. Caregiver burden among Chinese family caregivers of patients with lung cancer: A cross-sectional survey.
Hu X; Peng X; Su Y; Huang W
Eur J Oncol Nurs; 2018 Dec; 37():74-80. PubMed ID: 30473054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
